Open for bids Tender Germany ICB TOT Ref. 152592381

Conclusion of a Non-Exclusive Discount Agreement Tender - 152592381

Tender notice from Germany, published on 17 Nov 2026.

Executive Summary

Title/Summary: Tender for a non-exclusive discount agreement for the active ingredient Mometasone (excluding solution form) issued by DAK-Gesundheit in Hamburg, Germany, valid from January 1, 2027, to December 31, 2028, with an option for a 12-month extension.

Scope Of Work: The tender involves establishing a non-exclusive discount agreement for Mometasone, as per § 130a Abs. 8 SGB V, allowing statutory health insurance funds and pharmaceutical companies to enter framework discount contracts. The agreement will begin on January 1, 2027, and conclude on December 31, 2028, with the possibility of a 12-month extension. Bidders must submit offers for specified medications related to Mometasone as detailed in the contract's annex. All necessary documentation must be submitted electronically via email to DAK-Gesundheit by the specified deadlines.

Qualification Criterion: Bidders must submit a letter of offer, acknowledgment of DAK-Gesundheit's contractual terms, and completed annexes 1 and 2, detailing the medications to be included in the contract. All documents must be sent via email to [email protected]. The submission deadline for interested parties is the 5th of the month prior to the contract's start date. Late entries are permitted at designated times during the contract period.

Key facts

Summary
Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Mometasone (Exclusively in the Dafo Solution), Atc D07ac13 F. D. Z. 01.01.2027-31.12.2028 (Plus V. Option 1X12 M)
TOT Ref. No.
152592381
Document Ref. No.
Login to see
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
17 Nov 2026
Bid deadline
05 Nov 2029
EMD
Refer Document
Tender value
EUR 1.00
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Tender details are for registered users

Login to see details

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The last date to submit a bid for Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Mometasone (Exclusively in the Dafo Solution), Atc D07ac13 F. D. Z. 01.01.2027-31.12.2028 (Plus V. Option 1X12 M) is 05 Nov 2029. Submit before this date to be considered.

This tender has been issued by DAK HEALTH in Germany.

The estimated tender value is EUR 1.00. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 152592381. The purchaser document reference is available after login.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products, Technology and Equipment in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.